In Vivo Evaluation of an Adenoviral Vector Encoding Canine Factor VIII: High-Level, Sustained Expression in Hemophiliac Mice-Reference-Cited by-同舟云学术

In Vivo Evaluation of an Adenoviral Vector Encoding Canine Factor VIII: High-Level, Sustained Expression in Hemophiliac Mice

Published:1999-07-20 Issue:11 Volume:10 Page:1791-1802
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Gallo-Penn Angela M.,Shirley Pamela S.,Andrews Julie L.,Kayda Dawn B.,Pinkstaff Anne M.,Kaloss Michele,Tinlin Shawn,Cameron Cherie,Notley Colleen,Hough Christine,Lillicrap David,Kaleko Michael,Connelly Sheila

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/10430349950017473

Reference48 articles.

1. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A

2. The Canine Factor VIII cDNA and 5’ Flanking Sequence

3. Molecular cloning and mapping of a human cDNA (PA2G4) that encodes a protein highly homologous to the mouse cell cycle protein P38-2G4

4. Haemophilia A gene therapy

5. In VivoGene Delivery and Expression of Physiological Levels of Functional Human Factor VIII in Mice

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Therapy in Hemophilia A: Achievements, Challenges, and Perspectives;Seminars in Thrombosis and Hemostasis;2024-04-08

2. Tissue engineering and transplantation in the fetus;Principles of Tissue Engineering;2020

3. Prenatal Cell- and Gene-Based Therapies for Regenerative Medicine;Principles of Regenerative Medicine;2019

4. Evaluation of the biological differences of canine and human factor VIII in gene delivery: implications in human hemophilia treatment;Gene Therapy;2016-04-11

5. Canine models of inherited bleeding disorders in the development of coagulation assays, novel protein replacement and gene therapies;Journal of Thrombosis and Haemostasis;2016-04-05